Researcher Yang-Sun Hwang (left), Researcher You-Hyang Song (center), and Professor Seung-Hee Lee (right). Credit: The Korea Advanced Institute of Science and Technology (KAIST)

Researchers have confirmed that neuropeptide somatostatin can improve cognitive function in the brain. A research group of Professor Seung-Hee Lee from the Department of Biological Sciences at KAIST found that the application of neuropeptide somatostatin improves visual processing and cognitive behaviors by reducing excitatory inputs to parvalbumin-positive interneurons in the cortex.

This study, reported at Science Advances on April 22nd, sheds a new light on the therapeutics of neurodegenerative diseases. According to a recent study in Korea, one in ten seniors over 65 is experiencing dementia-related symptoms in their daily lives such as memory loss, cognitive decline, and motion function disorders. Professor Lee believes that somatostatin treatment can be directly applied to the recovery of cognitive functions in Alzheimer’s disease patients.

Professor Lee started this study noting the fact that the level of somatostatin expression was dramatically decreased in the cerebral cortex and cerebrospinal fluid of Alzheimer’s disease patients.

Somatostatin-expressing neurons in the cortex are known to exert the dendritic inhibition of pyramidal neurons via GABAergic transmission. Previous studies focused on their inhibitory effects on cortical circuits, but somatostatin-expressing neurons can co-release somatostatin upon activation. Despite the abundant expression of somatostatin and its receptors in the cerebral cortex, it was not known if somatostatin could modulate cognitive processing in the cortex.

  • A study finds neuropeptide somatostatin enhances visual processing
    Figure 1. Effects of SST and cyclo-SST injections on the visual discrimination performance of mice. Credit: The Korea Advanced Institute of Science and Technology (KAIST)
  • A study finds neuropeptide somatostatin enhances visual processing
    Figure. 2 SST increases the orientation selectivity and visual-evoked activity in the V1 of anesthetized mice. Credit: The Korea Advanced Institute of Science and Technology (KAIST)
  • A study finds neuropeptide somatostatin enhances visual processing
    Figure 3. PV+ neurons receive perisomatic excitatory synaptic inputs that are innervated by axons of SST neurons. Credit: The Korea Advanced Institute of Science and Technology (KAIST)

The research team demonstrated that the somatostatin treatment into the could enhance and cognitive behaviors in mice. The research team combined behaviors, in vivo and in vitro electrophysiology, and electron microscopy techniques to reveal how the activation of somatostatin receptors in vivo enhanced the ability of visual recognition in animals. Interestingly, somatostatin release can reduce excitatory synaptic transmission to another subtype of GABAergic interneurons, parvalbumin (PV)-expressing neurons.

As somatostatin is a stable and safe neuropeptide expressed naturally in the mammalian brain, it was safe to be injected into the and cerebrospinal fluid, showing a potential application to drug development for curing cognitive disorders in humans.

Professor Lee said, “Our research confirmed the key role of the neuropeptide SST in modulating cortical function and enhancing cognitive ability in the mammalian brain. I hope new drugs can be developed based on the function of to treat cognitive disabilities in many patients suffering from neurological disorders.”


Discovery of GABAergic synaptic regulations inside the brain for a new epilepsy treatment


More information:
You-Hyang Song et al. Somatostatin enhances visual processing and perception by suppressing excitatory inputs to parvalbumin-positive interneurons in V1, Science Advances (2020). DOI: 10.1126/sciadv.aaz0517

Citation:
A study finds neuropeptide somatostatin enhances visual processing (2020, April 23)
retrieved 23 April 2020
from https://medicalxpress.com/news/2020-04-neuropeptide-somatostatin-visual.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.





Source link